No results for ‘’
Kilitch Drugs (India) Ltd
₹183.80
(5.41%)
Tue, 26 May 2026, 00:33 am
Health Technology
Pharmaceuticals: Major
24.5KKilitch Drugs (India) Share Price Live Chart
1 Day
(5.41%)
No Result Found
Summary
Market Cap
646.79
Net Profit
24.94
P/B
2.87
Sector P/E
34.11
P/E
21.77
EV/EBITDA
14.47
Debt/Equity (Industry)
0.26
Interest Cover (Industry)
10.95
ROCE (Industry)
16.47
RONW (Industry)
14.44
ROE
11.68
ROCE
15.57
Debt/Equity
0.21
EPS (TTM)
8.63
Dividend Yield
0
Book Value
79.99
Interest Cover
6.73
Analysis
all
- Dividends paid are well covered by earnings (3.4x coverage).
- Kilitch Drugs (India) is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Kilitch Drugs (India) is profitable, therefore cash runway is not a concern.
- Kilitch Drugs (India) is profitable, therefore cash runway is not a concern.
- Debt is covered by short term assets, assets are 5.2x debt.
- Dividends per share have fallen over the past 10 years.
- Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
- Kilitch Drugs (India)'s pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Kilitch Drugs (India)'s dividend is below the markets top 25% of dividend payers in India (3.08%).
- Debt is not well covered by operating cash flow (2.2%, less than 20% of total debt).
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 63.77 | 63.77 | 63.77 | 69.23 | 69.23 |
| FII | 0.00 | 0 | 0.00 | 0.00 | 0 |
| DII | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public | 36.22 | 36.23 | 36.23 | 30.76 | 30.77 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 227.76 | 187.27 | 170.64 | 146.78 | 130.15 | 106.29 | 65.80 |
| Fibonacci | 187.27 | 171.80 | 162.24 | 146.78 | 131.31 | 121.75 | 106.29 |
| Camarilla | 165.15 | 161.44 | 157.73 | 146.78 | 150.31 | 146.60 | 142.89 |
Pivots Level: Classic
R3
+80.98
227.76
R2
+40.49
187.27
R1
+23.87
170.64
S1
-16.62
130.15
S2
-40.49
106.29
S3
-80.98
65.80
Moving Average
Period
Value
10-EMA
173.08
20-EMA
164.79
30-EMA
160.63
50-EMA
158.02
100-EMA
160.65
200-EMA
167.63
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 15 May 2026 | board-meetings | Accounts, Quarterly Results | |
| 18 Mar 2026 | bonus | 1:1 Bonus Issue of Equity Shares | 24 Mar 2026 |
| 11 Feb 2026 | board-meetings | Quarterly Results, Bonus Issue, EGM, Increase in Authorised Capital | |
| 11 Feb 2026 | egm | ||
| 13 Nov 2025 | board-meetings | Quarterly Results, Half Yearly Results | |
| 01 Sept 2025 | agm | ||
| 09 Jul 2025 | rights | 2:23 Rights Issue of Equity Shares | 15 Jul 2025 |
| 15 Jun 2025 | rights | Right Issue of Equity Shares | 15 Jul 2025 |
| 26 Aug 2024 | agm | ||
| 19 Aug 2024 | agm | Annual General Meeting | 20 Sept 2024 |
Peer Comparison
Kilitch Drugs (India) Ltd
Sun Pharmaceutical Industries Ltd
Dr Reddys Laboratories Ltd
Torrent Pharmaceuticals Ltd
Cipla Ltd
Divis Laboratories Ltd
Kilitch Drugs (India) Ltd About
Kilitch Drugs (India) in the manufacturing, supplying and marketing of broad range of pharmaceutical formulation in the various dosage from like Solid, Liquid and Parental across the globe with over three decades of experience.
Industry
Pharmaceuticals - Indian - Formulations
Founded
1992
Headquarters
CEO
Mukund P Mehta
Employees
Contact
Website
http://www.kilitch.com
info@kilitch.com
Phone
91-022-27670322/27680913/65144185
Location
C-301/2 MIDC TTC Indl Area, Pawane Village, Thane, Maharashtra, 400705
Kilitch Drugs (India) Ltd Company History
| Year | History |
|---|---|
| 2009 |
|
| 2010 |
|
| 2011 |
|
| 2015 |
|
| 2021 |
|
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| SHRENI SHARES PVT | bulk | Sell | 117495 | 405.58 | 28 Oct 2025 |
| SHRENI SHARES PVT | bulk | Buy | 32332 | 401.82 | 28 Oct 2025 |
| SHAH DIPAK KANAYALAL | bulk | Sell | 66699 | 96.35 | 06 Mar 2018 |
| BP FINTRADE PRIVATE LIMITED | bulk | Buy | 78214 | 96.36 | 06 Mar 2018 |
| BP FINTRADE PRIVATE LIMITED | bulk | Sell | 56811 | 98.98 | 06 Mar 2018 |
| SHAH DIPAK KANAYALAL | bulk | Sell | 80000 | 115.88 | 01 Mar 2018 |
| RONAK BANSAL | bulk | Sell | 72184 | 131.28 | 27 Feb 2018 |
| RONAK BANSAL | bulk | Buy | 72184 | 122.9 | 27 Feb 2018 |
| ANKUR TUKARAM MAYEKAR | bulk | Buy | 150200 | 85.23 | 22 Jan 2018 |
| ARUNA DINESH SHAH | bulk | Buy | 150400 | 89.32 | 22 Jan 2018 |